We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Efficacy of Topical Antifungal Agents in the Treatment of Dermatophytosis—Reply

Inajara Rotta, MSc1; Cassyano Januário Correr, PhD2
[+] Author Affiliations
1Pharmaceutical Sciences Postgraduate Program, Federal University of Parana, Curitiba, Brazil
2Department of Pharmacy, Federal University of Parana, Curitiba, Brazil
JAMA Dermatol. 2013;149(10):1244. doi:10.1001/jamadermatol.2013.5064.
Text Size: A A A
Published online


In Reply Our systematic review and mixed-treatment comparison meta-analysis showed no significant differences among 14 topical antifungal agents for mycologic cure.1 We also have found that butenafine, naftifine, and terbinafine might be the best treatments for maintaining a cure in patients with dermatophytosis.1 German language randomized clinical trials were not included in our review, which is 1 limitation of the study. Nevertheless, we believe that even if these studies were included, our results would not have changed significantly.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





October 1, 2013
Zbys Fedorowicz, MSc, DPH; Esther J van Zuuren, MD
1UK Cochrane Centre (Bahrain Branch), The Cochrane Collaboration, Awali, Bahrain
2Department of Dermatology, Leiden University Medical Centre, 2300 RC Leiden, the Netherlands
JAMA Dermatol. 2013;149(10):1243-1244. doi:10.1001/jamadermatol.2013.5065.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Related Collections